Can be extremely Lipitor patent difficult to split. To contact the reporter on this story: Susan Decker in Washington at (1) (202) 624-1941 or sdecker1bloomberg. "We will respond as appropriate to the issues raised by the examiner, and believe we have compelling arguments in our favor," said Pfizer General Counsel Allen Waxman. The move will likely force the firm to ramp up cost-cutting measures, stock repurchases and acquisition activity-actions likely, given the company’s scale, to have a knock-on effect throughout Big Pharma. Deutsche lipitor patent bank large cap pharma analyst Barbara Ryan speculated that layoffs could top 10,000 in the near future-about 10% of its workforce. In a statement issued at the weekend, Pfizer said it was lipitor patent in the process of contacting all those who were conducting the trial – known as the Illuminate trial – to inform them that all patients taking the medication should stop immediately. Of Federal District Court in Delaware ruled that two patents protecting atorvastatin, the active ingredient in Lipitor, are valid. We think ETC-2f6 could be Pfizer’s ticket to continued robust earnings growth after its Lipitor patents expire in 2006, S&P stated. Lipitor currently generates some $13bn lipitor patent ([pound]6. 5bn) a year for the company – about half of its annual profits. It is important to put this information in the context of both our commitment to transform Pfizer and our overall product and financial strength. Mr Kindler stressed that the group still had a diverse in-line and new product portfolio, adding that the end of the Torcetrapib trials would have no effect on the lipitor patent company’s profits in the current year. About Links Medical Products lipitor patent inc. Last week, the same court ruled that the basic patent would be infringed by Ranbaxy’s proposed generic atorvastatin product. Lipitor patent pfizer claims the anti-cholesterol product is safe from generic competition through 2011. Pfizer’s cholesterol-lowering drug Lipitor accounts for about 25 percent of its revenues. Background: Visiongain is one of the fastest growing and most innovative independent media companies in Europe today. That is already happening. Appeals court ruling that will lipitor patent keep a generic version of the cholesterol medicine Lipitor off the market until March 2010. Doctors as well as patients are getting wise and Lipitor patent ordering the maximum strength tablets and cutting them in half.